Optimizing Treatment for Locally Advanced Pancreas Cancer: Progress but No Precision.

摘要: If cancer is the emperor of all maladies, then pancreatic adenocarcinoma ruthless dictator cancers. In 2016, there will be an estimated 53 070 new diagnoses and 41 780 deaths from in United States.1 Pancreatic has recently surpassed breast (40 890 deaths) as a cause death States ranks below only lung colorectal number cancer-related annually.1 Globally, more than 340 000 cases are diagnosed each year incidence rates mortality nearly identical.2 Pancreas have not substantially declined over past decade, increasing low- middle-resource countries.